Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Surveillance Snapshot: HIV Pre-Exposure Prophylaxis (PrEP) Prescriptions Within the Active Component of the U.S. Military, 2023

Image of 36019063. HIV Pre-Exposure Prophylaxis is a highly effective medicine for preventing HIV when used as prescribed.

Click on the table to access a 508-compliant PDF versionHIV Pre-Exposure Prophylaxis is a highly effective medicine for preventing HIV when used as prescribed, reducing the risk of HIV from sex by around 99% and the risk of HIV from injection drug use by at least 74%.1 The Department of Defense follows the U.S. Centers for Disease Control and Prevention HIV PrEP guidelines for identification of individuals eligible for HIV PrEP and their evaluation and monitoring.2 This Surveillance Snapshot was created to determine the number of active component service members prescribed PrEP during 2023. 

Data from the Defense Medical Surveillance System were used for this analysis.3 The population was restricted to ACSMs who received a PrEP prescription between January 1, 2023 and December 31, 2023. A PrEP prescription was defined as a record in the Pharmacy Data Transaction System or Theater Medical Data Store medication files within DMSS containing the drug name Truvada, Descovy, Emtricitabine, Tenofovir, Apretude, or Cabotegravir. Records with the names Disoproxil, Viread, or Emtricitabine or listing a therapeutic class of 081808 (antiretrovirals) were excluded, as those are HIV treatment medications. Additionally, a prescription record was excluded if an individual had a diagnosis of chronic hepatitis B or HIV on or before the prescription date, or a needlestick diagnosis within 30 days before or after the prescription date. 

An individual was counted once during the surveillance year. Counts were summarized by pharmacy type, demographic characteristics, service-related variables, and self-assessed sexually-transmitted infection risk (defined from the Periodic Health Assessment if completed within one year prior to the prescription date) (Table). 

There were 4,495 ACSMs with a prescription for HIV PrEP in 2023 (Table). The majority of prescriptions (79%) were obtained directly from a military clinic. The demographic groups with the highest numbers of prescriptions were 25-29 year olds (1,307), males (4,155), non-Hispanic Whites (1,772), and single, never married (2,865) ACSMs. In evaluating service-related characteristics, the highest number of prescriptions were among Army and Navy service members (1,526 and 1,452, respectively), enlisted (1,664 junior and 1,695 senior), communications/intelligence occupations (1,287), stationed in the U.S. (3,483), and in service for 3-10 years (2,164). The majority of service members with a prescription had a self-assessed risk for a STI (46%), but this information was unknown for 31% of the total PrEP recipients. 

These data provide an overview of ACSMs receiving HIV PrEP in 2023 and can be used to further evaluate subpopulations within the ACSM population that may have a missed opportunity for receiving HIV PrEP. 

Authors’ Affiliation

Epidemiology and Analysis Branch, Armed Forces Health Surveillance Division, Defense Health Agency: Dr. Eick-Cost, Dr. Mabila, and Dr. Ying 

Disclaimer

The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views, assertions, opinions, nor policies of the Defense Health Agency or the Department of Defense. 

References

  1. Centers for Disease Control and Prevention. Pre-Exposure Prophylaxis (PrEP). Accessed Feb. 26, 2024. https://www.cdc.gov/hiv/risk/prep/index.html
  2. Defense Health Agency. Defense Health Agency Procedural Instruction 6025.29: Provision of Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) for Persons at High Risk of Acquiring HIV Infection. Department of Defense. Updated Dec. 20, 2019. Accessed Feb. 26, 2024. https://www.health.mil/Reference-Center/DHA-Publications/2019/12/20/DHA-PI-6025-29 
  3. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92(12):1900-1904.

You also may be interested in...

Report
May 1, 2024

MSMR Vol. 31 No. 5 - May 2024

.PDF | 3.55 MB

The May 2024 MSMR features a report on mortality surveillance of active duty U.S. soldiers from 2014 to 2019; followed by three related reports on respiratory investigations, surveillance and forecasting, on: an outbreak of influenza and SARS-CoV-2 at the Armed Forces of the Philippines Health Service Education and Training Center, September–October ...

Report
Mar 1, 2024

MSMR Vol. 31 No. 3 - March 2024

.PDF | 1.34 MB

The March 2024 MSMR features a comparison of 2018 estimates from the HRBS and the PHA on tobacco and nicotine use among the U.S. military active component; followed by a report on coverage of HIV PrEP among active duty service members in 2023; supplemented by a Surveillance Snapshot of HIV PrEP prescriptions in 2023 in the active component; then a ...

Report
Oct 1, 2023

MSMR Vol. 30 No. 10 - October 2023

.PDF | 1.29 MB

The October 2023 Medical Surveillance Monthly Report (MSMR) provides a review of the incidence of colorectal cancer among active component service members from 2010 to 2022; followed by a study of force protection risks in AFRICOM, INDOPACOM, and SOUTHCOM due to rapid diagnostic test failures for P. falciparum malaria from 2016 to 2022; then an update ...

Report
Sep 1, 2023

MSMR Vol. 30 No. 9 - September 2023

.PDF | 1.30 MB

The September 2023 MSMR provides the annual update of routine screening for antibodies to HIV among the active and reserve components of the U.S. Armed Forces; followed by a serological survey of Ross River virus (RRV) infection among U.S. Marine expeditionary forces who train in Australia; followed by a Surveillance Snapshot of the 10 leading ...

Report
Aug 1, 2023

MSMR Vol. 30 No. 8 - August 2023

.PDF | 1.02 MB

The August 2023 MSMR provides the most recent data from the active surveillance program for acute respiratory disease and Group A Beta-Hemolytic Streptococcus among U.S. Army basic trainees; then summarizes the case report of an extensively resistant E. coli in a returning traveler at Hawai'i's Tripler Army Medical Center; followed by a Surveillance ...

Report
Jul 1, 2023

MSMR Vol. 30 No. 7 - July 2023

.PDF | 1.30 MB

This continuation of the June issue, which published the annual quantification of health care provided by the Military Health System, continues with the impacts of various illnesses and injuries in 2022 among deployed service members; medical evacuations out of theaters of military operation; health care provision to non-service member MHS ...

Report
Jun 1, 2023

MSMR Vol. 30 No. 6 - June 2023

.PDF | 1.55 MB

This annual issue quantifies the impacts of various illnesses and injuries in 2022 among members of the active component of the U.S. Armed Forces as well as the U.S. Coast Guard; health care burden metrics include the total number of medical encounters, including hospitalizations and ambulatory services, as well as numbers and types of individuals ...

Report
May 1, 2023

MSMR Vol. 30 No. 5 - May 2023

.PDF | 1023.59 KB

The May 2023 MSMR reintroduces a monthly reportable medical event (RME) summary for the active component and MHS beneficiaries; then features a review of enhanced mpox outbreak case detection among MHS beneficiaries through ESSENCE (Electronic Surveillance System for the Early Notification of Community-based Epidemics); followed by a report on ...

Skip subpage navigation
Refine your search
Last Updated: May 07, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery